Chieh-Lin Jerry Teng
Overview
Explore the profile of Chieh-Lin Jerry Teng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
329
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Y, Lin C, Su Y, Teng C
Hematology
. 2025 Feb;
30(1):2462249.
PMID: 39913258
Background: The current study aimed to compare treatment responses, the incidence of the need for auto-HSCT, and the occurrence of specific adverse events (AEs) between VTD and velcade, VRD induction...
2.
Wu T, Hsiao T, Chen C, Li H, Hung M, Jhan P, et al.
Clin Proteomics
. 2025 Jan;
22(1):3.
PMID: 39833682
Background: The standard "7 + 3" induction results in 30% of de novo acute myeloid leukemia (AML) patients not achieving complete remission (CR). We aimed to utilize the Olink platform...
3.
Chen C, Chen T, Wu T, Hsiao T, Chen J, Huang C, et al.
J Cell Mol Med
. 2024 Dec;
28(24):e70306.
PMID: 39720891
Leukaemia stem cells (LSCs) are major contributors to chemoresistance in acute myeloid leukaemia (AML). Identifying potential biomarkers within LSCs that can predict chemosensitivity in AML is key. This prospective study...
4.
Yu C, Liao Y, Chiang C, Chen J, Pan H, Pan C, et al.
J Transl Med
. 2024 Dec;
22(1):1095.
PMID: 39623468
Background: Bortezomib is a standard treatment for multiple myeloma (MM), working by the accumulation of toxic misfolded proteins in cancer cells. However, a significant clinical challenge arises from the development...
5.
Kao W, Chiu K, Tsai S, Teng C, Oner M, Lai C, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Nov;
1871(2):167568.
PMID: 39536992
Aberrant PI3K/Akt activation is linked to prostate cancer (PCa) malignancy, while androgen receptor (AR) is critical in early-stage PCa development. Investigating the interaction between these pathways is crucial for PCa...
6.
Kao W, Liao L, Chen Y, Lo U, Pong R, Hernandez E, et al.
Cell Death Dis
. 2024 Sep;
15(9):678.
PMID: 39284838
SPHK1 (sphingosine kinase type 1) is characterized as a rate-limiting enzyme in sphingolipid metabolism to phosphorylate sphingosine into sphingosine-1-phosphate (S1P) that can bind to S1P receptors (S1PRs) to initiate several...
7.
Teng C, Yeh S, Chen T, Hung Y, Lin Y, Li S, et al.
Hematology
. 2024 Jul;
29(1):2365096.
PMID: 38958506
Background/purpose: The treatment landscape of relapsed/refractory multiple myeloma (RRMM) is rapidly evolving in Taiwan. The present study aimed to assess the treatment patterns among RRMM patients in Taiwan. Methods: This...
8.
Liao P, Lu H, Chen T, Lin H, Shih Y, Teng C
Cancer Rep (Hoboken)
. 2024 May;
7(5):e2102.
PMID: 38775249
Background: Thalidomide-containing regimens cause adverse events (AEs) that may require a reduction in treatment intensity or even treatment discontinuation in patients with multiple myeloma. As thalidomide toxicity is dose-dependent, identifying...
9.
Tseng K, Hsu C, Shih Y, Lin H, Li Y, Teng C, et al.
Ther Adv Med Oncol
. 2024 May;
16:17588359241247019.
PMID: 38716478
Background: The limited efficacy of chemotherapy in improving survival in pancreatic ductal adenocarcinoma (PDAC) necessitates the exploration of novel strategies to overcome treatment resistance. Objectives: This study aimed to investigate...
10.
Wang Y, Lai C, Chen T, Gau J, Teng C
Cancer Rep (Hoboken)
. 2024 Apr;
7(4):e2060.
PMID: 38600053
Background: Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) has emerged as an effective approach for acute leukemia, primarily due to the inherent difficulty in finding human leukocyte antigen-matched unrelated donors (MUD)....